Literature DB >> 8550827

Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells.

J C Tsai1, H Wang, M A Perrella, M Yoshizumi, N E Sibinga, L C Tan, E Haber, T H Chang, R Schlegel, M E Lee.   

Abstract

Homocysteine is an important and independent risk factor for arteriosclerosis. We showed previously that homocysteine stimulates vascular smooth muscle cell proliferation, a hallmark of arteriosclerosis. We show here that homocysteine and serum increased DNA synthesis synergistically in both human and rat aortic smooth muscle cells (RASMCs). Treatment of quiescent RASMCs with 1 mM homocysteine or 2% calf serum for 36 h increased cyclin A mRNA levels by 8- and 14-fold, respectively, whereas homocysteine plus serum increased cyclin A mRNA levels by 40-fold, indicating a synergistic induction of cyclin A mRNA. Homocysteine did not increase the half-life of cyclin A mRNA (2.9 h), but it did increase the transcriptional rate of the cyclin A gene in nuclear run-on experiments. The positive effect of homocysteine on cyclin A gene transcription was confirmed by our finding that homocysteine increased cyclin A promoter activity and ATF-binding protein levels in RASMCs. Finally, 1 mM homocysteine increased cyclin A protein levels and cyclin A-associated kinase activity by threefold. This homocysteine-induced expression lesions by promoting proliferation of vascular smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550827      PMCID: PMC507073          DOI: 10.1172/JCI118383

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians.

Authors:  M J Stampfer; M R Malinow; W C Willett; L M Newcomer; B Upson; D Ullmann; P V Tishler; C H Hennekens
Journal:  JAMA       Date:  1992-08-19       Impact factor: 56.272

2.  Modulation of cell growth, p34cdc2 and cyclin A levels by SV-40 large T antigen.

Authors:  J Oshima; K E Steinmann; J Campisi; R Schlegel
Journal:  Oncogene       Date:  1993-11       Impact factor: 9.867

3.  Cyclin E and cyclin A as candidates for the restriction point protein.

Authors:  Q P Dou; A H Levin; S Zhao; A B Pardee
Journal:  Cancer Res       Date:  1993-04-01       Impact factor: 12.701

4.  Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication.

Authors:  M C Cardoso; H Leonhardt; B Nadal-Ginard
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

5.  Localization of cyclin A at the sites of cellular DNA replication.

Authors:  J Sobczak-Thepot; F Harper; Y Florentin; F Zindy; C Brechot; E Puvion
Journal:  Exp Cell Res       Date:  1993-05       Impact factor: 3.905

6.  Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study.

Authors:  M R Malinow; F J Nieto; M Szklo; L E Chambless; G Bond
Journal:  Circulation       Date:  1993-04       Impact factor: 29.690

7.  Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor.

Authors:  K A Hajjar
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

Review 8.  The pathogenesis of atherosclerosis: a perspective for the 1990s.

Authors:  R Ross
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

9.  The ATF site mediates downregulation of the cyclin A gene during contact inhibition in vascular endothelial cells.

Authors:  M Yoshizumi; C M Hsieh; F Zhou; J C Tsai; C Patterson; M A Perrella; M E Lee
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

10.  Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum.

Authors:  S R Lentz; J E Sadler
Journal:  Blood       Date:  1993-02-01       Impact factor: 22.113

View more
  30 in total

1.  The inducible cAMP early repressor ICERIIgamma inhibits CREB and AP-1 transcription but not AT1 receptor gene expression in vascular smooth muscle cells.

Authors:  X Wang; T J Murphy
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

2.  Hyperhomocysteinemia in patients with Behçet's disease: is it due to inflammation or therapy?

Authors:  Zeki Yesilova; Salih Pay; Cagatay Oktenli; Ugur Musabak; Kenan Saglam; S Yavuz Sanisoglu; Kemal Dagalp; M Kemal Erbil; Ismail H Kocar
Journal:  Rheumatol Int       Date:  2004-04-01       Impact factor: 2.631

3.  Association between MTHFR C677T polymorphism and osteonecrosis of the femoral head: a meta-analysis.

Authors:  Xi-fu Shang; Hong Su; Wei-wei Chang; Chen-cheng Wang; Qin Han; Zhi-wei Xu
Journal:  Mol Biol Rep       Date:  2012-02-07       Impact factor: 2.316

4.  Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition.

Authors:  Hong Wang; XiaoHua Jiang; Fan Yang; Gary B Chapman; William Durante; Nicholas E S Sibinga; Andrew I Schafer
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

Review 5.  The genetics of vascular complications in diabetes mellitus.

Authors:  Dan Farbstein; Andrew P Levy
Journal:  Cardiol Clin       Date:  2010-08       Impact factor: 2.213

Review 6.  Homocysteine to hydrogen sulfide or hypertension.

Authors:  Utpal Sen; Paras K Mishra; Neetu Tyagi; Suresh C Tyagi
Journal:  Cell Biochem Biophys       Date:  2010-07       Impact factor: 2.194

Review 7.  Putative mechanisms for vascular damage by homocysteine.

Authors:  M F Bellamy; I F McDowell
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

8.  Differential regulation of homocysteine transport in vascular endothelial and smooth muscle cells.

Authors:  Xiaohua Jiang; Fan Yang; Eugen Brailoiu; Hieronim Jakubowski; Nae J Dun; Andrew I Schafer; Xiaofeng Yang; William Durante; Hong Wang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-09       Impact factor: 8.311

9.  Molecular mechanisms underlying the anti-proliferative and anti-migratory effects of folate on homocysteine-challenged rat aortic smooth muscle cells.

Authors:  Ying Chou; Hui-Chen Lin; Kuan-Chou Chen; Chi-Cheng Chang; Wen-Sen Lee; Shu-Hui Juan
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

10.  Translational upregulation of folate receptors is mediated by homocysteine via RNA-heterogeneous nuclear ribonucleoprotein E1 interactions.

Authors:  Aśok Antony; Ying-Sheng Tang; Rehana A Khan; Mangatt P Biju; Xiangli Xiao; Qing-Jun Li; Xin-Lai Sun; Hiremagalur N Jayaram; Sally P Stabler
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.